Cargando…

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis

BACKGROUND: The choice between upfront surgery or neoadjuvant treatments (NAT) for resectable pancreatic ductal adenocarcinoma (R-PDAC) is controversial. R-PDAC with potential nodal involvement could benefit from NT. Ca (Carbohydrate antigen) 19.9 and serum albumin levels, alone or in combination, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coppola, Alessandro, La Vaccara, Vincenzo, Fiore, Michele, Farolfi, Tommaso, Ramella, Sara, Angeletti, Silvia, Coppola, Roberto, Caputo, Damiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190389/ https://www.ncbi.nlm.nih.gov/pubmed/34123859 http://dx.doi.org/10.3389/fonc.2021.690580

Ejemplares similares

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments”
por: Coppola, Alessandro, et al.
Publicado: (2022)

Different Biliary Microbial Flora Influence Type of Complications after Pancreaticoduodenectomy: A Single Center Retrospective Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Role of Neoplastic Markers in Pancreatic Adenocarcinoma
por: Coppola, Alessandro, et al.
Publicado: (2022)

Right hepatic artery anomalies in pancreatoduodenectomy—a risk for arterial resection but not for postoperative outcomes
por: La Vaccara, Vincenzo, et al.
Publicado: (2023)

Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2023)

New Frontiers of Early Diagnosis of Pancreatic Fistula after Pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2022)

Data of postoperative complications related to fibrinogen-to-albumin ratio in pancreatic resections()
por: La Vaccara, V., et al.
Publicado: (2022)

Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles
por: Digiacomo, Luca, et al.
Publicado: (2021)

Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review
por: Fiore, Michele, et al.
Publicado: (2023)

Preoperative systemic inflammatory biomarkers and postoperative day 1 drain amylase value predict grade C pancreatic fistula after pancreaticoduodenectomy
por: Caputo, Damiano, et al.
Publicado: (2020)

Validations of new cut-offs for surgical drains management and use of computerized tomography scan after pancreatoduodenectomy: The DALCUT trial
por: Caputo, Damiano, et al.
Publicado: (2022)

Utility of preoperative systemic inflammatory biomarkers in predicting postoperative complications after pancreaticoduodenectomy: Literature review and single center experience
por: Coppola, Alessandro, et al.
Publicado: (2021)

Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma
por: Lottini, Tiziano, et al.
Publicado: (2023)

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival
por: Morales-Oyarvide, Vicente, et al.
Publicado: (2017)

Nanotechnology and pancreatic cancer management: State of the art and further perspectives
por: Caputo, Damiano, et al.
Publicado: (2021)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Clinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma
por: CHOI, SUNG HOON, et al.
Publicado: (2013)

Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma
por: Pande, Rupaly, et al.
Publicado: (2022)

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
por: Fiore, Michele, et al.
Publicado: (2017)

A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio
por: Song, Yunda, et al.
Publicado: (2018)

Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection
por: Caputo, Damiano, et al.
Publicado: (2023)

International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma
por: Joliat, Gaëtan-Romain, et al.
Publicado: (2022)

A Bio-Imaging Signature as a Predictor of Clinical Outcomes in Locally Advanced Pancreatic Cancer
por: Fiore, Michele, et al.
Publicado: (2020)

Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report
por: Masui, Toshihiko, et al.
Publicado: (2013)

Survival in resectable pancreatic ductal adenocarcinoma with para-aortic lymph node dissection: A retrospective study in Vietnamese population
por: Nguyen, Lan Thi, et al.
Publicado: (2021)

Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts
por: Andersen, Lise Mari K., et al.
Publicado: (2017)

Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma
por: Suzuki, Yukie, et al.
Publicado: (2020)

Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
por: Shin, Jaehoon, et al.
Publicado: (2020)

Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2019)

Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022)

A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Gao, Jiahao, et al.
Publicado: (2020)

Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma
por: Speichinger, Fiona, et al.
Publicado: (2021)

The Site of Lymph Node Metastasis: A Significant Prognostic Factor in Pancreatic Ductal Adenocarcinoma
por: Aysal, Anil, et al.
Publicado: (2022)

Comment on: “Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma”
por: Zheng, Yangyang, et al.
Publicado: (2023)

Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail
por: Matsui, Yuki, et al.
Publicado: (2022)

Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
por: Fiore, Michele, et al.
Publicado: (2021)

Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective study
por: Wang, Ankang, et al.
Publicado: (2020)

Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?
por: Lahat, G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_63bhvbrrpma95jo761pef6g5tm